Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A new infusion method for a prostacyclin analogue]

L Pibiri1, P Petruzzo, D Angius

  • 1Dipartimento Scienze Chirurgiche, Università degli Studi, Cagliari.

Minerva Cardioangiologica
|May 13, 1998
PubMed
Summary

A novel home infusion pump for Iloprost (prostaglandin I2) therapy in severe limb ischemia patients demonstrated patient appreciation and reduced hospital stays. This method offers a less expensive treatment option for peripheral artery disease (PAD).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of flow magnetic resonance imaging in the monitoring of facial allotransplantations: preliminary results on graft vasculopathy.

International journal of oral and maxillofacial surgery·2019
Same author

Successful pregnancy after uterine artery embolization for uterine arterovenous malformation: a rare case report.

International journal of women's health·2018
Same author

Colonic adenosquamous carcinoma and mucinous adenocarcinoma with microsatellite instability.

The Malaysian journal of pathology·2018
Same author

Medico legal aspects on neuromonitoring in thyroid surgery: informed consent on malpractice claims.

Il Giornale di chirurgia·2017
Same author

Face Transplantation: Partial Graft Loss of the First Case 10 Years Later.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015

Area of Science:

  • Vascular Medicine
  • Pharmacology
  • Biomedical Engineering

Context:

  • Severe limb ischemia, often due to peripheral artery disease (PAD), typically requires prolonged hospitalization for intravenous Iloprost therapy.
  • Traditional Iloprost infusion involves daily 6-hour intravenous administration in a hospital setting over 28 days.
  • Iloprost, a stable prostaglandin I2 analogue, is crucial for managing critical limb ischemia.

Purpose:

  • To evaluate the efficacy and patient acceptance of a novel home infusion pump system for delivering Iloprost to patients with severe limb ischemia.
  • To assess the feasibility of transitioning Iloprost therapy from hospital to home settings using a portable infusion device.
  • To determine if home-based Iloprost infusion impacts treatment outcomes and healthcare costs.

Summary:

Related Experiment Videos

  • A 28-day Iloprost infusion therapy was administered to 30 patients with severe PAD using a novel home pump after an initial 3-day hospital infusion.
  • High-performance liquid chromatography (HPLC) studies confirmed the structural integrity of Iloprost within the home pump, ensuring continuous delivery of active isomers.
  • The home pump system allowed for continuous Iloprost infusion at 2 ml/h, with reservoir refills every six days.

Impact:

  • The home infusion system was well-received by patients, enabling a more normal lifestyle and significantly reducing hospital stay duration to 3 days.
  • Treatment outcomes included complete pain relief and ulcer healing in 9 patients, improvement in 6 patients, with 4 major amputations and 1 death among the 30 participants.
  • The home pump system represents a cost-effective alternative to traditional inpatient Iloprost administration for severe limb ischemia and PAD.